GH1 and acromegaly: In the low GH <6-ng/dl group, a higher percentage of patients achieved disease control with SRL compared to patients with higher basal GH, thus reinforcing the concept that acromegaly is a heterogeneous disease even at older ages and that the disease characteristics per se and not age are what determine clinical behavior and therapeutic response.